Market Cap ₹- Cr.
Stock P/E
P/B -
Current Price ₹291.8
Book Value ₹ 0
Face Value 275
52W High ₹310
Dividend Yield 0%
52W Low ₹ 242.9
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|
Net Sales | 131 | 877 | 1197 | 1780 | |
Other Income | 5 | 22 | 32 | 79 | |
Total Income | 136 | 899 | 1229 | 1859 | |
Total Expenditure | 48 | 258 | 381 | 532 | |
Operating Profit | 88 | 641 | 848 | 1327 | |
Interest | 41 | 208 | 432 | 852 | |
Depreciation | 32 | 208 | 275 | 411 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 15 | 224 | 140 | 64 | |
Provision for Tax | -10 | -22 | 9 | 68 | |
Profit After Tax | 25 | 246 | 131 | -4 | |
Adjustments | -0 | 0 | 0 | 27 | |
Profit After Adjustments | 25 | 246 | 131 | 24 | |
Adjusted Earnings Per Share | 0.8 | 7.4 | 3.9 | 0.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 49% | 139% | 0% | 0% |
Operating Profit CAGR | 56% | 147% | 0% | 0% |
PAT CAGR | -103% | NAN% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 17% | -1% | NA% | NA% |
ROE Average | -0% | 1% | 1% | 1% |
ROCE Average | 5% | 4% | 3% | 3% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Shareholder's Funds | 8203 | 8882 | 8334 | 10256 |
Minority's Interest | 0 | 0 | 0 | 2006 |
Borrowings | 2102 | 5099 | 5398 | 11185 |
Other Non-Current Liabilities | -74 | -154 | -125 | -11 |
Total Current Liabilities | 501 | 583 | 664 | 1715 |
Total Liabilities | 10731 | 14410 | 14272 | 25150 |
Fixed Assets | 10 | 16 | 19 | 41 |
Other Non-Current Assets | 10334 | 14019 | 13833 | 24366 |
Total Current Assets | 387 | 375 | 420 | 743 |
Total Assets | 10731 | 14410 | 14272 | 25150 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 316 | 204 | 210 |
Cash Flow from Operating Activities | 140 | 606 | 953 | 1433 |
Cash Flow from Investing Activities | -48 | -1403 | -109 | -2144 |
Cash Flow from Financing Activities | 146 | 667 | -838 | 756 |
Net Cash Inflow / Outflow | 238 | -130 | 5 | 45 |
Closing Cash & Cash Equivalent | 316 | 204 | 210 | 370 |
# | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|
Earnings Per Share (Rs) | 0.83 | 7.35 | 3.92 | 0.54 |
CEPS(Rs) | 1.88 | 13.57 | 12.13 | 9.27 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 270.89 | 265.07 | 248.7 | 233.57 |
Core EBITDA Margin(%) | 63.03 | 70.52 | 68.13 | 70.13 |
EBIT Margin(%) | 42.78 | 49.3 | 47.86 | 51.46 |
Pre Tax Margin(%) | 11.41 | 25.57 | 11.73 | 3.62 |
PAT Margin (%) | 19.32 | 28.09 | 10.96 | -0.22 |
Cash Profit Margin (%) | 43.51 | 51.87 | 33.95 | 22.87 |
ROA(%) | 0.24 | 1.96 | 0.92 | -0.02 |
ROE(%) | 0.31 | 2.88 | 1.52 | -0.04 |
ROCE(%) | 0.54 | 3.55 | 4.12 | 5.08 |
Receivable days | 67.28 | 9.7 | 11.29 | 12.78 |
Inventory Days | 0 | 0 | 0 | 0 |
Payable days | 0 | 8228.53 | 4301.16 | 4206.1 |
PER(x) | 267.4 | 42.51 | 71.28 | 473.62 |
Price/Book(x) | 0.82 | 1.18 | 1.12 | 1.09 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 65.14 | 17.55 | 12.16 | 12.74 |
EV/Core EBITDA(x) | 97.26 | 24.01 | 17.16 | 17.09 |
Net Sales Growth(%) | 0 | 569.6 | 36.52 | 48.75 |
EBIT Growth(%) | 0 | 671.63 | 32.52 | 59.95 |
PAT Growth(%) | 0 | 873.34 | -46.72 | -102.94 |
EPS Growth(%) | 0 | 780.89 | -46.71 | -86.28 |
Debt/Equity(x) | 0.26 | 0.58 | 0.65 | 1.17 |
Current Ratio(x) | 0.77 | 0.64 | 0.63 | 0.43 |
Quick Ratio(x) | 0.77 | 0.64 | 0.63 | 0.43 |
Interest Cover(x) | 1.36 | 2.08 | 1.32 | 1.08 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# |
---|
Promoter |
FII |
DII |
Public |
Others |
Total |
# |
---|
Promoter |
FII |
DII |
Public |
Others |
Total |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About